agilon health (NYSE:AGL) Shares Down 5% – Should You Sell?

agilon health, inc. (NYSE:AGLGet Free Report) dropped 5% on Monday . The stock traded as low as $2.79 and last traded at $2.83. Approximately 480,161 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 4,923,468 shares. The stock had previously closed at $2.98.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on AGL shares. Benchmark reissued a “buy” rating and set a $9.00 price target on shares of agilon health in a report on Thursday, August 8th. Evercore ISI reduced their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 8th. Royal Bank of Canada restated an “outperform” rating and issued a $8.00 target price on shares of agilon health in a research report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft dropped their price target on agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Finally, Bank of America lowered agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target on the stock. in a research report on Wednesday, October 2nd. Two equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $8.03.

Get Our Latest Stock Report on agilon health

agilon health Stock Down 6.0 %

The stock has a market cap of $1.15 billion, a price-to-earnings ratio of -4.00 and a beta of 0.54. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04. The firm’s 50 day moving average is $3.87 and its two-hundred day moving average is $5.23.

agilon health (NYSE:AGLGet Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.07). The business had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The business’s revenue was up 38.7% on a year-over-year basis. During the same period last year, the business earned ($0.04) EPS. On average, sell-side analysts predict that agilon health, inc. will post -0.32 EPS for the current year.

Insider Activity at agilon health

In other news, CEO Steven Sell bought 20,000 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was bought at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the acquisition, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. This represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. 3.20% of the stock is currently owned by insiders.

Institutional Trading of agilon health

A number of institutional investors and hedge funds have recently modified their holdings of the company. J.Safra Asset Management Corp grew its position in shares of agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares during the last quarter. CWM LLC grew its stake in shares of agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after acquiring an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC acquired a new position in agilon health during the 2nd quarter valued at $60,000. Bleakley Financial Group LLC acquired a new stake in agilon health in the 1st quarter worth $65,000. Finally, Allspring Global Investments Holdings LLC lifted its stake in shares of agilon health by 17,790.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock valued at $70,000 after buying an additional 10,674 shares during the period.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Stories

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.